Overview

Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
An Open-Label, Non-Randomized, Uncontrolled, Single-dose Pilot Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Beijing Tongren Hospital